2 months ago
ANIP
AnalystsGregory FraserGregory Fraser's Stock Forecasts
AnalystsGregory Fraser
Analyst Ranking
Top 17%
#757 out of 4563 analysts
Average Return
+10.91%
Win Rate
56%15 out of 27
Risk vs Reward
Poor
Good
Gregory Fraser's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amneal Pharmaceuticals IncAMRX | +362.60% | $1.31 | $6.06 | 2023-03-29 - 2024-03-28 | Strong Buy |
Evolus IncEOLS | +89.89% | $5.54 | $10.52 | 2022-01-20 - 2023-01-19 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +63.51% | $3.70 | $6.05 | 2023-09-06 - 2024-04-24 | Strong Buy |
Corcept Therapeutics IncCORT | +55.20% | $17.61 | $27.33 | 2022-01-28 - 2022-08-01 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +49.01% | $4.06 | $6.05 | 2023-11-08 - 2024-04-24 | Strong Buy |
Gregory Fraser Analyst Color
Get additional color on Gregory Fraser's coverage of popular stocks
2 years ago
XAIR
Gregory Fraser's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ani Pharmaceuticals IncANIP | 6 | Strong Buy | $80.00 | +22.27% | Maintains | 2 months ago |
Biote CorpBTMD | 2 | Strong Buy | $9.00 | +61.00% | Maintains | 3 months ago |
Beyond Air IncXAIR | 5 | Strong Buy | $10.00 | +681.25% | Maintains | 5 months ago |
Amneal Pharmaceuticals IncAMRX | 4 | Strong Buy | $7.00 | +15.70% | Maintains | 6 months ago |
Corcept Therapeutics IncCORT | 5 | Hold | $29.00 | +29.00% | Maintains | 9 months ago |
Novocure LtdNVCR | 3 | Strong Buy | $95.00 | +669.85% | Reiterates | a year ago |
Evolus IncEOLS | 2 | Strong Buy | $18.00 | +56.52% | Maintains | a year ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $40.00 | +357.14% | Maintains | a year ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Bausch Health Companies IncBHC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 2 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.